Scientists test 'Smart Bomb' drug to fight tough head and neck cancers
NCT ID NCT07408063
Summary
This study is testing a new type of targeted cancer drug, GSK5764227, for people with advanced head and neck cancer that has returned or spread. The drug works like a 'smart bomb' that seeks out cancer cells and delivers a chemotherapy agent directly to them. Researchers will give the drug alone to some patients and combined with another immunotherapy drug to others, to see how well it works and to learn what biological markers predict a good response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.